To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot

This is an ongoing work built upon the previous work of HITAP in developing and improving the pay-for-performance scheme for primary care services through Quality and Outcome Framework (QOF). This phrase is particularly focusing on developing the dialogue of QOF use and its implementation with policy makers.Documents

This project aims to strengthened Thai health system post COVID times and has been started since 1 April 2022 until the end of March 2023. There are five sub-projects under the grant consisting of environmental health, local governance, health financing, and digital technology.

This virtual workshop was provided for public health professionals, researchers, and policy makers from Ghana, Malawi, and Tanzania. The course covered topics such as political economy of vaccinology, vaccine policy and distribution, and the science of vaccines, with a specific focus on the COVID-19 pandemic and COVID-19 vaccines.

Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions.   The

Antimicrobial resistance (AMR) will continue to significantly impact healthcare and public health around the world. Given the complexity of AMR and the multi-dimensional nature of its aetiology and impact, a multi-sectoral and inter-disciplinary approach is required to mitigate its impact. “One Health” is an approach to designing and implementi

National HTA methods and process guidelines (hereon in referred to as HTA guidelines) have been identified as a key factor in establishing a well-functioning HTA system (1,2). A number of resources already exist for countries seeking to develop their own HTA guidelines, such as the Practical Guide on Evidence-Informed Deliberative Processes, the iD

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve